- Category
- Micro (2020-21)
- Udyam number
- UDYAM-MH-33-0013644

Cetus Pharmaceutical Private Limited
About Cetus Pharmaceutical Private Limited
Data last updated:
Cetus Pharmaceutical Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51397MH2020PTC344128.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shashi Mewalal Verma and Sonam Shashi Verma.
Its last annual general meeting (AGM) was held on 05 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 10 Garden View Chs Sector 19 Airoli, Navi Mumbai, Maharashtra, India – 400708.
As per the financials filed for FY 2025, the company reported a revenue of ₹34.11 Lakh, a growth of 31% compared to the previous year. For the same year it recorded a net profit of ₹25,340 (net margin 0.7%) and EBITDA of ₹1.04 Lakh (EBITDA margin 3%). Revenue has grown at a compounded annual rate (CAGR) of 120% over three years.
Cetus Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0013644).
Company details
Recognitions & Rankings of Cetus Pharmaceutical
Contact details
Cetus Pharmaceutical Private Limited's registered office is in Navi Mumbai, Maharashtra.
- Registered AddressShop No. 10 Garden View Chs Sector 19 Airoli, Navi Mumbai, Maharashtra, India – 400708
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cetus Pharmaceutical is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Cetus Pharmaceutical Private Limited, buy the company report.
Financials of Cetus Pharmaceutical Private Limited
FY 2025 filings availableCetus Pharmaceutical Private Limited reported revenue of ₹34.11 Lakh (up 31% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 120% over three years, including 31% growth in the latest year. EBITDA rose 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.04 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹25,340 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cetus Pharmaceutical Private Limited, buy the company report.
Board of directors of Cetus Pharmaceutical Private Limited
Cetus Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shashi Mewalal Verma | Director | 20 Aug 2020 | 6 Years 2 Months | Current |
| Sonam Shashi Verma | Director | 20 Aug 2020 | 6 Years 2 Months | Current |
Peer comparison
Cetus Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sires Biotics Private Limited | ₹36.25 Lakh (FY 2025) | Nizamabad, Telangana, India | ||||
| Metabolyte Life Sciences Private Limited | ₹35.91 Lakh (FY 2024) | 162.0% | Bangalore, Karnataka, India | |||
| Advanced Qa Services (OPC) Private Limited | ₹35.77 Lakh (FY 2025) | Chennai, Tamil Nadu, India | ||||
| Nature Life Remedies Private Limited | ₹35.15 Lakh (FY 2025) | -6.0% | Pune, Maharashtra, India | |||
| Avychem Pharma Private Limited | ₹34.51 Lakh (FY 2025) | 41.0% | Bilaspur, Haryana, India | |||
| Cetus Pharmaceutical Private Limitedthis company | ₹34.11 Lakh (FY 2025) | ₹25,340 | 0.7% | 31.0% | Navi Mumbai, Maharashtra, India | |
| Medikay Pharma Private Limited | ₹33.64 Lakh (FY 2025) | -5.0% | New Delhi, Delhi, India | |||
| Etheric Remedies Private Limited | ₹33.37 Lakh (FY 2024) | 427.0% | Delhi, India | |||
| Drati Pharmaceuticals Private Limited | ₹33.29 Lakh (FY 2024) | -10.0% | Thane, Maharashtra, India | |||
| Reskon Pharmaceutical Private Limited | ₹33.22 Lakh (FY 2024) | 71.0% | Thane, Maharashtra, India | |||
| Vetrich Animal Health Care Private Limited | ₹33.22 Lakh (FY 2025) | 6.0% | Pune, Maharashtra, India |
To see the full peer comparison of Cetus Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Cetus Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cetus Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Cetus Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Cetus Pharmaceutical Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Shashi Mewalal Verma was appointed as Director on 20 Aug 2020.
Frequently asked questions
Cetus Pharmaceutical is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 August 2020 (6+ years old) and is registered under CIN U51397MH2020PTC344128.
Cetus Pharmaceutical has 2 current directors:
- Shashi Mewalal Verma - Director
- Sonam Shashi Verma - Director
The latest financial statements of Cetus Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 05 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Cetus Pharmaceutical is U51397MH2020PTC344128. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cetus Pharmaceutical was incorporated on 20 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Cetus Pharmaceutical by revenue are Sires Biotics Private Limited, Metabolyte Life Sciences Private Limited, Advanced Qa Services (OPC) Private Limited, Nature Life Remedies Private Limited, Avychem Pharma Private Limited and 5 more, all in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Shashi Mewalal Verma was appointed as Director on 20 Aug 2020. Sonam Shashi Verma was appointed as Director on 20 Aug 2020.
Yes, Cetus Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0013644).
The registered office of Cetus Pharmaceutical is at Shop No. 10 Garden View Chs Sector 19 Airoli, Navi Mumbai, Maharashtra, India – 400708.
Cetus Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Cetus Pharmaceutical can be reached at its registered office: Shop No. 10 Garden View Chs Sector 19 Airoli, Navi Mumbai, Maharashtra, India – 400708.